Tag: clinicaltrials

Renaissance Pharma secures FDA Fast Track Designation and IND clearance for Daretabart in high-risk neuroblastoma

AbbVie’s Elahere succeeds in phase 2 platinum-sensitive ovarian cancer trial

Oragenics doses first patient in phase 2a clinical trial of drug for mild traumatic brain injury

Lynk Pharmaceuticals announces NDA acceptance for zemprocitinib

MetaVia doses the first patient in higher-dose phase 1 study of DA-1726, Its GLP-1 and glucagon dual agonist for the treatment of obesity

Ideaya Biosciences and Servier announce positive topline results from phase 2/3 registrational trial of darovasertib in combination with crizotinib in first-line negative metastatic uveal...

GSK presents positive data for B7-H4-targeted ADC in gynaecological cancers

UCB announces new clinical data from its generalised myasthenia gravis (gMG) portfolio

Ebglyss (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis

Bimzelx (bimekizumab-bkzx) data shows durable symptom control throughout three years in hidradenitis suppurativa